BSEBoard Meeting6d ago · 9 Oct 2026, 04:18 pm

Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2026 ,inter alia, to consider and approve unaudited financial results of the Company for the quarter and half year ended September 30, 2026

Solara Active Pharma Sciences Ltd · 541540

✦ AI SummaryResults

Solara Active Pharma Sciences Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 16/10/2026 to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment7/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Quarter And Half Year Ended September 30, 2026

Attachments (1)

📄

db86abe6-0835-4495-b2dc-3f26f9808e14.pdf

pdf

Download →
View document text
Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Date: October 09, 2026 The BSE Limited The National Stock Exchange of India Phiroze Jeejeebhoy Towers Limited Dalal Street, Mumbai – 400 001 Exchange Plaza, C-1, Block G, Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol : SOLARA, SOLARAPP1 Dear Sir / Madam, Sub: Intimation regarding Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (“Listing Regulations”) This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday, October 16, 2026, to consider and approve the unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026, amongst other matters. Further, in accordance with the Company's Code of Conduct for Prohibition of Insider Trading, adopted by the Board pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company is closed for the designated persons from October 01, 2026, till 48 hours after the announcement of financial results of the Company. The above information will also be available on website of the Company at www.solara.co.in This is for your kind information. Thanking you, Yours faithfully, For Solara Active Pharma Sciences Limited Pooja Jaya Kumar Company Secretary & Compliance Officer Membership No: A57415 Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91-22- 20870033